ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 141 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 2.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $566,000 | +62.2% | 30,017 | +17.3% | 0.01% | +25.0% |
| Q1 2019 | $349,000 | -12.5% | 25,596 | -34.3% | 0.00% | -20.0% |
| Q4 2018 | $399,000 | -46.4% | 38,953 | -12.9% | 0.01% | -44.4% |
| Q3 2018 | $745,000 | +97.1% | 44,735 | +86.7% | 0.01% | +80.0% |
| Q2 2018 | $378,000 | -80.9% | 23,955 | -84.6% | 0.01% | -83.9% |
| Q1 2018 | $1,978,000 | +451.0% | 155,711 | +396.6% | 0.03% | +416.7% |
| Q4 2017 | $359,000 | -21.8% | 31,358 | +125.6% | 0.01% | -88.0% |
| Q4 2015 | $459,000 | +37.4% | 13,900 | +120.6% | 0.05% | -53.7% |
| Q2 2015 | $334,000 | – | 6,300 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 6,402,366 | $128,496,000 | 6.43% |
| Cormorant Asset Management, LP | 150,000 | $3,011,000 | 0.80% |
| PFM Health Sciences, LP | 738,027 | $14,812,000 | 0.30% |
| Partner Investment Management, L.P. | 27,893 | $560,000 | 0.11% |
| Spark Investment Management LLC | 32,100 | $642,000 | 0.10% |
| PointState Capital LP | 275,000 | $5,519,000 | 0.07% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 97,809 | $1,963,000 | 0.06% |
| CADIAN CAPITAL MANAGEMENT, LP | 100,000 | $2,007,000 | 0.06% |
| Nicholas Investment Partners, LP | 50,456 | $1,013,000 | 0.06% |
| Baker Brothers Advisors | 153,350 | $3,078,000 | 0.04% |